Rhea J. Posedel, Director at AEHR TEST SYSTEMS (AEHR), sold 400 shares at $29.95 ($12K) on 2023-01-11, disclosed to the SEC on 2023-01-13.
Scheduled sale ($12k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AEHR | SELL | 2026-04-22 | $1.8M | — | Filing → |
| AEHR | SELL | 2026-04-21 | $844K | — | Filing → |
| AEHR | SELL | 2026-04-20 | $661K | — | Filing → |